Health
‘Baricitinib’: This arthritis drug may improve Covid survival in elderlies – ummid.com
This is one of the first Covid-19 treatments to go from computer to clinic and laboratory, study authors said
London: Scientists have claimed that a type of arthritis drug called ‘baricitinib’ may reduce the risk of dying among elderly patients infected with Covid-19.
This medication is usually used to treat rheumatoid arthritis, and was initially identified by the Imperial College London using artificial intelligence as a drug that could have anti-viral and anti-inflammatory effects.
In the early-stage study, 83 patients, with a median age of 81 and all suffering from moderate to severe COVID-19 infection,…
-
General21 hours agoOf saints and sinners | The Spectator Australia
-
General22 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News12 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General22 hours agoWhy the nation needs the Nationals to ditch Net Zero